CHARLESTON, S.C.--(BUSINESS WIRE)--Aug. 30, 2006--Paul J. Price, Ph.D. has been named the chief scientific officer of D-Finitive Technologies, Inc., a Charleston-based biotechnology company focused on cord blood stem cell research. Dr. Price, who recently retired from GIBCO Invitrogen, has been active in the areas of cell culture and media development since 1958.
